Skip to main content
ukiyo journal - 日本と世界をつなぐ新しいニュースメディア Logo
  • All Articles
  • 🗒️ Register
  • 🔑 Login
    • 日本語
    • 中文
    • Español
    • Français
    • 한국어
    • Deutsch
    • ภาษาไทย
    • हिंदी
Cookie Usage

We use cookies to improve our services and optimize user experience. Privacy Policy and Cookie Policy for more information.

Cookie Settings

You can configure detailed settings for cookie usage.

Essential Cookies

Cookies necessary for basic site functionality. These cannot be disabled.

Analytics Cookies

Cookies used to analyze site usage and improve our services.

Marketing Cookies

Cookies used to display personalized advertisements.

Functional Cookies

Cookies that provide functionality such as user settings and language selection.

A Future Where Home Lights Heal? A Day When LED Burns "Only Cancer" ─ Can Affordable Light Therapy Surpass the Side Effects of Chemotherapy?

A Future Where Home Lights Heal? A Day When LED Burns "Only Cancer" ─ Can Affordable Light Therapy Surpass the Side Effects of Chemotherapy?

2025年10月26日 00:26

1. What Happened? — "LED×Nano" Paves the Way for "Gentle" Cancer Treatment

Chemotherapy and radiation therapy remain standard treatments, but side effects like severe fatigue and skin disorders are unavoidable. This is where low-invasive treatments using light come into focus. The latest report demonstrates a method that targets and "heats and destroys" cancer cells by combining near-infrared LEDs with SnOx (tin oxide) nanoflakes. The key point is replacing conventional lasers with more affordable and user-friendly LEDs. The research was conducted by a team from the University of Texas at Austin (UT Austin) and the University of Porto.The Independent


2. Breaking Down the Mechanism: What is Photothermal Therapy?

  • Photothermal therapy (PTT) is a physical approach where materials that absorb light generate heat, which then kills tumor cells.

  • In this study, SnS₂ powder was oxidized through a water-based process and converted into SnOx nanoflakes that absorb near-infrared (NIR) light well. These nanoflakes locally heat up under LED irradiation to destroy cancer cells.Localized heating destroys cancer cells.PubMed


Near-infrared light has a relatively high biopenetrability wavelength range, allowing it to safely reach the skin's surface to shallow layers. While laser devices are expensive, high-powered, and pose risks of damaging healthy tissue with installation constraints, LEDs are low-cost and portable, making them suitable for uniform irradiation and leading to visions like home-use patches.The Independent


3. How Effective Was It? — Current Evidence

  • In cultured cell experiments, up to 92% of skin cancer cells and **50% of colon cancer cells were killed with 30 minutes of LED irradiation.No harmful effects were observed on healthy human skin cells. However, this is still at the in vitro (test tube) stage**, and there is no human clinical data yet.news.utexas.edu

  • The academic paper (ACS Nano) details that the synthesis of SnOx is scalable through a green process (water-based) and effective as a PTT agent with an LED light source.PubMed

Supplement: In cancer treatments using light, there are multiple approaches such as photodynamic therapy (PDT) and photobiomodulation (PBM). While PDT induces chemical reactions with drugs and light, PTT destroys with heat. PBM has accumulated evidence for alleviating side effects, with reviews on reducing oral mucositis, dermatitis, and lymphedema. The SnOx×LED approach is positioned as **"directly targeting cancer cells with heat" PTT**.Lymphoedema Education Solutions


4. What's "New" — From Lasers to LEDs

In the world of PTT, gold nanoparticles + lasers have been mainstream. The highlight of the new method is the LED-based light source and the availability of materials. LEDs are affordable, easy to control heat, and offer high installation flexibility. The research team envisions clinical implementation like a patch-type device applied to postoperative wounds. Lowering costs could expand its reach to resource-limited areas.The Independent


5. Expectations vs. Reality: The Distance to Clinical Application

  • Challenge ① Penetration Depth: Even with near-infrared, the depth of penetration is limited. It is initially suitable for superficial skin cancers and residual microscopic lesions in postoperative wounds, while deep organ cancers require additional strategies (wavelength, light guidance, implants).The Independent

  • Challenge ② In Vivo Dynamics of Nanomaterials: Evaluation of long-term toxicity, metabolism/excretion, and immune responses is essential. The paper indicates water-based synthesis and biocompatibility, but GLP toxicity tests and regulatory pathways are yet to come.PubMed

  • Challenge ③ Energy Delivery Management: Overheating directly leads to damage to healthy tissue. Implementing temperature feedback and irradiation control is key.

  • Challenge ④ Comparative Trials: Randomized trials are needed to demonstrate non-inferiority/superiority compared to laser PTT, PDT, immunotherapy, and molecular targeted drugs.

Note that PBM (low-power red and near-infrared light) is advancing in clinical application for side effect alleviation, but it is not a treatment to "eliminate" cancer. It is not advisable to improperly substitute with commercially available red light devices. Trials and implementation under medical supervision are prerequisites.MD Anderson Cancer Center


6. Potential for Combination Strategies

Heat stress may influence the membrane permeability and immunogenic cell death of tumors, suggesting potential synergistic effects when combined with immunotherapy and drug delivery. Research combining smart delivery of phototherapy and chemotherapy is increasing.Cancer Today


7. Reading SNS Reactions (Posts from 10/12 to 10/25)

 


The topic rapidly spread on X (formerly Twitter) and Reddit. While excitement grew over **"the potential for home treatment" and "92% destruction rate", there were also premature claims like "chemotherapy is no longer needed."**

  • On X, many posts simplified the research summary, with numbers like **"810nm near-infrared LED" and "92% of skin cancer cells in 30 minutes" circulating independently. Medical accounts cautioned that "there is still no clinical data. Excessive expectations are prohibited."**X (formerly Twitter)

  • On Reddit, comments correcting misconceptions like **"Can it be cured at home?" were highly ranked, clarifying that "it's currently a cell experiment" and "the equipment and materials are specialized." The discussion tone was generally optimistic 7: skeptical 3**.Reddit

  • News summary posts and scientific media were the starting points for the spread, with many posts linking to UT Austin's official announcement as primary information.news.utexas.edu

Editorial Comment: The issue of "spread speed > review speed" in scientific reporting was exposed again. Visualizing the path from **"cultured cells → animals → early clinical" and clearly indicating "what stage we are at now"** can help prevent misunderstandings.


8. Checklist from the Perspective of Patients and Families

  • This is not yet clinical (effectiveness and safety in humans are unconfirmed).PubMed

  • The initial promise is in the areas of superficial skin cancer and postoperative adjuvant. Additional technologies are needed for deep cancers.The Independent

  • Do not repurpose household red light devices for treatment purposes. PBM and PTT are different.MD Anderson Cancer Center

  • When clinical trials begin, always check the target cancer types, exclusion criteria, and irradiation conditions.

  • "Zero side effects" do not exist. Be informed about the possibilities of burns, pigmentation, and pain.


9. Conclusion: Can LEDs Become "Standard" in Medicine?

This study is innovative in addressing both effectiveness (selective cell death) and accessibility (LEDs and water-based synthesis). Reducing the cost and improving the usability of medical devices

← Back to Article List

Contact |  Terms of Service |  Privacy Policy |  Cookie Policy |  Cookie Settings

© Copyright ukiyo journal - 日本と世界をつなぐ新しいニュースメディア All rights reserved.